About EurexOTC Clear
EMIR 3.0 - active account
CCP Switch
On-boarding
Compression Service
Product Scope
Interest Rate Swaps
Inflation Swaps
Settlement Prices
Service Offering for PSAs
Clearing Member
ISA Direct Member
ISA Direct Light Licence Holder
Clearing Agent
Client
Jurisdictions
Multiple Clearing Relationships
Segregation Set up
Cross-Project-Calendar
Readiness for projects
C7 Releases
C7 SCS Releases
C7 CAS Releases
EurexOTC Clear Releases
Prisma Releases
Member Section Releases
Simulation calendar
Archive
User ID Maintenance
Clearing Hours
Clearing Reports
Product Specifications
Clearing on behalf
Delivery Management
Transaction Management
Collateral Management
Collateral
Transparency Enabler Files
Segregation Models
Reports
Default Fund
Intraday Margin Calls
OTC Clear Procedures
OTC Clear Tutorials
Cross Margining Support
Supplementary Margins
Default Waterfall
Model Validation
Stress testing
Default Management Process
Client Asset Protection under EMIR
Client Asset Protection under LSOC
Credit, concentration & wrong way risk
System-based risk controls
Pioneering CCP Transparency
Haircut and adjusted exchange rates
Securities margin groups and classes
Prices Rolling Spot Future
File services
Bond Clusters
Listed derivatives
OTC derivatives
Listed securities
Cash management
Delivery management
CCP eligible instruments
Eurex Newsletter Subscription
Circulars & Newsflashes Subscription
Corporate Action Information Subscription
Circulars & Readiness Newsflashes
News
Videos
Webcasts on demand
Publications
Forms
Events
FAQs
Production Newsboard
Eurex
Market wrap-up
We all will keep 2020 as an unprecedent year in mind. From a market and equity derivatives perspective the year can be divided into two parts. During the first half year we experienced a unique market environment with high volatility and sudden shifts in operational trading setups. Even more disruptive for the equity options segment was certainly the uncertainty around postponed AGMs and the subsequent fallouts or reductions in dividend payments. The second half year was rather dominated by the massive rally in equity markets firstly driven by the technology sector and after the vaccine approvals also supported by cyclicals and financials. For the equity options segments all those developments offered a lot of opportunities which is reflected in an overall increase in volumes in 2020 of 2%. We’d like to express again our gratitude to our on-screen and off-book liquidity providers and highlight their exceptional performance. Thanks to them, we saw orderly and functioning markets, able to absorb extraordinarily high volumes, despite difficult operational circumstances.
In 2021 we start with the launch of a new options segment by listing equity options on Xetra listed US underlyings, denominated in EUR. Options will be listed on: Tesla, Facebook, Apple, Amazon, Google, Netflix and Microsoft. The offering will allow customers to trade US equity options during European hours on a regulated European trading platform and the benefits of cross margin efficiencies and we are very happy to have support from our liquidity providers to actively quote the segment.






On-screen liquidity has fairly stabilized in the course of 2020 after some disrupted weeks around March/April. Especially the available BBO volumes of the German and the Swiss segment is back at it’s highs compared to the previous year accompanied by stable spreads.
Updates on our Equity Derivatives
Part 1: The impact of ICB on STOXX indices
Giulio Castelli, Head of Benchmarks, Strategies and Specialty Themes at Qontigo and Zubin Ramdarshan, Head of Equity and Index Product Design at Eurex, provide their understanding of how to understand what the new indices mean for very popular derivatives.
Part 2: The impact of ICB on indices and related derivatives
Stephan Flaegel from Qontigo and Randolf Roth from Eurex are talking about the new Industry Classification Benchmark (ICB) structure and its impact on indices and related derivatives. The main discussion points were the general impact and how the transition from the old to new ICB classifications has evolved.
